Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.

Spaic T, Driscoll M, Raghinaru D, Buckingham BA, Wilson DM, Clinton P, Chase HP, Maahs DM, Forlenza GP, Jost E, Hramiak I, Paul T, Bequette BW, Cameron F, Beck RW, Kollman C, Lum JW, Ly TT; In-Home Closed-Loop (IHCL) Study Group.

Diabetes Care. 2017 Mar;40(3):359-366. doi: 10.2337/dc16-1794. Epub 2017 Jan 18.

2.

Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension.

Wadwa RP, Chase HP, Raghinaru D, Buckingham BA, Hramiak I, Maahs DM, Messer L, Ly T, Aye T, Clinton P, Kollman C, Beck RW, Lum J; In Home Closed Loop Study Group.

Pediatr Diabetes. 2017 Sep;18(6):422-427. doi: 10.1111/pedi.12410. Epub 2016 Jul 12.

3.

Prevention of Hypoglycemia Using the Predicted Low Glucose Suspend System.

Chase HP.

Diabetes Technol Ther. 2016 May;18(5):276-7. doi: 10.1089/dia.2016.0119. No abstract available.

PMID:
27159781
4.

Effects of Frequency of Sensor-Augmented Pump Use on HbA1c and C-Peptide Levels in the First Year of Type 1 Diabetes.

Triolo TM, Maahs DM, Pyle L, Slover R, Buckingham B, Cheng P, DiMeglio LA, Bremer AA, Weinzimer SA, Chase HP; Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups.

Diabetes Care. 2016 Apr;39(4):e61-2. doi: 10.2337/dc15-2201. Epub 2016 Feb 19. No abstract available.

5.

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197-1204.

Buckingham BA, Raghinaru D, Cameron F, Bequette BW, Chase HP, Maahs DM, Slover R, Wadwa RP, Wilson DM, Ly T, Aye T, Hramiak I, Clarson C, Stein R, Gallego PH, Lum J, Sibayan J, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2015 Sep;38(9):1813. doi: 10.2337/dc15-er09. No abstract available.

6.

Downloading Diabetes Device Information.

Chase HP, Owen SL, Slover RH.

Diabetes Technol Ther. 2015 Aug;17(8):534-5. doi: 10.1089/dia.2015.0172. Epub 2015 May 20. No abstract available.

PMID:
26237306
7.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.

Buckingham BA, Raghinaru D, Cameron F, Bequette BW, Chase HP, Maahs DM, Slover R, Wadwa RP, Wilson DM, Ly T, Aye T, Hramiak I, Clarson C, Stein R, Gallego PH, Lum J, Sibayan J, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2015 Jul;38(7):1197-204. doi: 10.2337/dc14-3053. Epub 2015 Jun 6. Erratum in: Diabetes Care. 2015 Sep;38(9):1813.

8.

Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S; T1D Exchange Clinic Network.

Diabetes Care. 2015 Apr;38(4):e61. doi: 10.2337/dc14-2782. No abstract available.

PMID:
25805875
9.

Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.

Wilson DM, Calhoun PM, Maahs DM, Chase HP, Messer L, Buckingham BA, Aye T, Clinton PK, Hramiak I, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Technol Ther. 2015 Jun;17(6):385-91. doi: 10.1089/dia.2014.0342. Epub 2015 Mar 11.

10.

Diabetes technology and therapy in the pediatric age group.

Shalitin S, Chase HP.

Diabetes Technol Ther. 2015 Feb;17 Suppl 1:S96-S108. doi: 10.1089/dia.2015.1512. No abstract available.

PMID:
25679436
11.

A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas.

Baysal N, Cameron F, Buckingham BA, Wilson DM, Chase HP, Maahs DM, Bequette BW; In Home Closed-Loop Study Group (IHCL).

J Diabetes Sci Technol. 2014 Nov;8(6):1091-6. doi: 10.1177/1932296814553267. Epub 2014 Oct 14.

12.

Changing the hemoglobin A1c goals for children with type 1 diabetes.

Ullrich RL, Chase HP.

Diabetes Technol Ther. 2014 Oct;16(10):611-2. doi: 10.1089/dia.2014.0219. No abstract available.

PMID:
25271369
13.

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

Chase HP, Doyle FJ 3rd, Zisser H, Renard E, Nimri R, Cobelli C, Buckingham BA, Maahs DM, Anderson S, Magni L, Lum J, Calhoun P, Kollman C, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):623-32. doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.

14.

Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes.

Chase HP, Boulware D, Rodriguez H, Donaldson D, Chritton S, Rafkin-Mervis L, Krischer J, Skyler JS, Clare-Salzler M; Type 1 Diabetes TrialNet Nutritional Intervention to Prevent (NIP) Type 1 Diabetes Study Group.

Pediatr Diabetes. 2015 Jun;16(4):271-9. doi: 10.1111/pedi.12170. Epub 2014 Jul 12.

15.

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S; T1D Exchange Clinic Network.

Diabetes Care. 2014 Oct;37(10):2702-9. doi: 10.2337/dc14-0303. Epub 2014 Jul 10.

16.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Zisser H, Renard E, Kovatchev B, Cobelli C, Avogaro A, Nimri R, Magni L, Buckingham BA, Chase HP, Doyle FJ 3rd, Lum J, Calhoun P, Kollman C, Dassau E, Farret A, Place J, Breton M, Anderson SM, Dalla Man C, Del Favero S, Bruttomesso D, Filippi A, Scotton R, Phillip M, Atlas E, Muller I, Miller S, Toffanin C, Raimondo DM, De Nicolao G, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):613-22. doi: 10.1089/dia.2014.0066. Epub 2014 Jul 8. Erratum in: Diabetes Technol Ther. 2015 Jan;17(1):68. Vistenin, Roberto [corrected to Visentin, Roberto].

17.

A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.

Maahs DM, Calhoun P, Buckingham BA, Chase HP, Hramiak I, Lum J, Cameron F, Bequette BW, Aye T, Paul T, Slover R, Wadwa RP, Wilson DM, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2014 Jul;37(7):1885-91. doi: 10.2337/dc13-2159. Epub 2014 May 7.

18.

Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system.

Beck RW, Raghinaru D, Wadwa RP, Chase HP, Maahs DM, Buckingham BA; In Home Closed Loop Study Group.

Diabetes Care. 2014;37(5):1224-9. doi: 10.2337/dc13-2775.

19.

Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.

Blackman SM, Raghinaru D, Adi S, Simmons JH, Ebner-Lyon L, Chase HP, Tamborlane WV, Schatz DA, Block JM, Litton JC, Raman V, Foster NC, Kollman CR, DuBose SN, Miller KM, Beck RW, DiMeglio LA.

Pediatr Diabetes. 2014 Dec;15(8):564-72. doi: 10.1111/pedi.12121. Epub 2014 Feb 4.

PMID:
24494980
20.

Diabetes technology and therapy in the pediatric age group.

Shalitin S, Chase HP.

Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S100-9. doi: 10.1089/dia.2014.1512. No abstract available.

PMID:
24479590
21.

The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes.

Maahs DM, Chase HP, Westfall E, Slover R, Huang S, Shin JJ, Kaufman FR, Pyle L, Snell-Bergeon JK.

Diabetes Technol Ther. 2014 May;16(5):284-91. doi: 10.1089/dia.2013.0227. Epub 2014 Jan 22.

PMID:
24450776
22.

First test effect in intravenous glucose tolerance testing.

Ismail HM, White KS, Krischer JP, Chase HP, Cuthbertson D, Palmer JP; DPT-1 Study Group.

Pediatr Diabetes. 2015 Mar;16(2):129-37. doi: 10.1111/pedi.12064. Epub 2013 Aug 15.

23.

Possibility to reduce diabetic ketoacidosis-related mortality in type 1 diabetes: prevention versus treatment.

Realsen J, Goettle H, Chase HP.

Diabetes Technol Ther. 2013 Sep;15(9):787. doi: 10.1089/dia.2013.0124. Epub 2013 Aug 9. No abstract available.

PMID:
23931741
24.

Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.

Buckingham BA, Cameron F, Calhoun P, Maahs DM, Wilson DM, Chase HP, Bequette BW, Lum J, Sibayan J, Beck RW, Kollman C.

Diabetes Technol Ther. 2013 Aug;15(8):622-7. doi: 10.1089/dia.2013.0040. Epub 2013 Jul 24.

25.

Diabetes technology and treatment in the pediatric age group.

Shalitin S, Chase HP.

Diabetes Technol Ther. 2013 Feb;15 Suppl 1:S107-16. doi: 10.1089/dia.2013.1512. Review. No abstract available.

PMID:
23441699
26.

Navigating airport security with an insulin pump and/or sensor.

Cornish A, Chase HP.

Diabetes Technol Ther. 2012 Nov;14(11):984-5. doi: 10.1089/dia.2012.0220. Epub 2012 Oct 19. No abstract available.

PMID:
23083374
27.

Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.

Cameron F, Wilson DM, Buckingham BA, Arzumanyan H, Clinton P, Chase HP, Lum J, Maahs DM, Calhoun PM, Bequette BW.

J Diabetes Sci Technol. 2012 Sep 1;6(5):1142-7.

28.

Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.

Realsen J, Goettle H, Chase HP.

Diabetes Technol Ther. 2012 Dec;14(12):1149-54. doi: 10.1089/dia.2012.0161. Epub 2012 Sep 25. Review.

PMID:
23009106
29.

The increasing onset of type 1 diabetes in children.

Hummel K, McFann KK, Realsen J, Messer LH, Klingensmith GJ, Chase HP.

J Pediatr. 2012 Oct;161(4):652-7.e1. doi: 10.1016/j.jpeds.2012.03.061. Epub 2012 May 12.

PMID:
22578579
30.

Recent advances in the prevention of hypoglycemia in type 1 diabetes.

Realsen JM, Chase HP.

Diabetes Technol Ther. 2011 Dec;13(12):1177-86. doi: 10.1089/dia.2011.0150. Epub 2011 Sep 20. Review.

PMID:
21932997
31.

Outcome measures for outpatient hypoglycemia prevention studies.

Beck RW, Kollman C, Xing D, Buckingham BA, Chase HP.

J Diabetes Sci Technol. 2011 Jul 1;5(4):999-1004.

32.

Metabolic tests to determine risk for type 1 diabetes in clinical trials.

Greenbaum CJ, Buckingham B, Chase HP, Krischer J; Diabetes Prevention Trial, Type 1 Diabetes (DPT-1) Study Group.

Diabetes Metab Res Rev. 2011 Sep;27(6):584-9. doi: 10.1002/dmrr.1205.

33.

Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Fiallo-Scharer R, Cheng J, Beck RW, Buckingham BA, Chase HP, Kollman C, Laffel L, Lawrence JM, Mauras N, Tamborlane WV, Wilson DM, Wolpert H.

Diabetes Care. 2011 Mar;34(3):586-90. doi: 10.2337/dc10-1111. Epub 2011 Jan 25.

34.

Factors affecting improved glycaemic control in youth using insulin pumps.

Wilkinson J, McFann K, Chase HP.

Diabet Med. 2010 Oct;27(10):1174-7. doi: 10.1111/j.1464-5491.2010.03068.x.

PMID:
20854386
35.

Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes.

Taplin CE, Cobry E, Messer L, McFann K, Chase HP, Fiallo-Scharer R.

J Pediatr. 2010 Nov;157(5):784-8.e1. doi: 10.1016/j.jpeds.2010.06.004. Epub 2010 Jul 21.

36.

Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.

Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ.

Diabetes Technol Ther. 2010 Jul;12(7):507-15. doi: 10.1089/dia.2010.0021.

PMID:
20597824
37.

The use of insulin pumps in youth with type 1 diabetes.

Maahs DM, Horton LA, Chase HP.

Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S59-65. doi: 10.1089/dia.2009.0161.

38.

Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas.

Dassau E, Cameron F, Lee H, Bequette BW, Zisser H, Jovanovic L, Chase HP, Wilson DM, Buckingham BA, Doyle FJ 3rd.

Diabetes Care. 2010 Jun;33(6):1249-54. doi: 10.2337/dc09-1487.

39.

Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension.

Buckingham B, Chase HP, Dassau E, Cobry E, Clinton P, Gage V, Caswell K, Wilkinson J, Cameron F, Lee H, Bequette BW, Doyle FJ 3rd.

Diabetes Care. 2010 May;33(5):1013-7. doi: 10.2337/dc09-2303. Epub 2010 Mar 3.

40.

Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.

Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, Chase HP.

Diabetes Technol Ther. 2010 Mar;12(3):173-7. doi: 10.1089/dia.2009.0112.

PMID:
20151766
41.

Missed insulin boluses for snacks in youth with type 1 diabetes.

Vanderwel BW, Messer LH, Horton LA, McNair B, Cobry EC, McFann KK, Chase HP.

Diabetes Care. 2010 Mar;33(3):507-8. doi: 10.2337/dc09-1840. Epub 2009 Dec 23.

42.

A pilot trial of pramlintide home usage in adolescents with type 1 diabetes.

Kishiyama CM, Burdick PL, Cobry EC, Gage VL, Messer LH, McFann K, Chase HP.

Pediatrics. 2009 Nov;124(5):1344-7. doi: 10.1542/peds.2008-3750. Epub 2009 Oct 26.

PMID:
19858155
43.

Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension.

Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP.

Diabetes Technol Ther. 2009 Feb;11(2):93-7. doi: 10.1089/dia.2008.0032.

44.

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV.

Diabetes Care. 2009 Nov;32(11):1947-53. doi: 10.2337/dc09-0889. Epub 2009 Aug 12.

45.

Continuous glucose monitoring in youth with type 1 diabetes.

Wadwa RP, Fiallo-Scharer R, Vanderwel B, Messer LH, Cobry E, Chase HP.

Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S83-91. doi: 10.1089/dia.2008.0122.

PMID:
19469682
46.

Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study.

Chase HP, Lutz K, Pencek R, Zhang B, Porter L.

J Pediatr. 2009 Sep;155(3):369-73. doi: 10.1016/j.jpeds.2009.03.012. Epub 2009 May 21.

PMID:
19464026
47.

Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

Triolo TM, Chase HP, Barker JM; DPT-1 Study Group.

Diabetes Care. 2009 May;32(5):769-73. doi: 10.2337/dc08-1872.

48.

Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes.

Burdick P, Cooper S, Horner B, Cobry E, McFann K, Chase HP.

Pediatr Diabetes. 2009 Apr;10(2):116-9. doi: 10.1111/j.1399-5448.2008.00449.x. Epub 2009 Jan 7.

PMID:
19175512
49.

Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.

White NH, Chase HP, Arslanian S, Tamborlane WV; 4030 Study Group.

Diabetes Care. 2009 Mar;32(3):387-93. doi: 10.2337/dc08-0800. Epub 2008 Dec 23.

50.

Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D.

N Engl J Med. 2008 Oct 2;359(14):1464-76. doi: 10.1056/NEJMoa0805017. Epub 2008 Sep 8.

Supplemental Content

Loading ...
Support Center